Trial NCT04526990
Publication Halperin SA, Lancet, 2021
Primary outcome on the report: 1) incidence of serious adverse events and medically attended adverse events after vaccination; 2) prevention of symptomatic, real-time PCR-confirmed COVID-19 infection occurring 28 days after vaccination

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.